Overview
This educational initiative focuses on improving the management of patients at risk for venous thromboembolism (VTE), which is a substantial cause of morbidity and mortality despite the availability of evidence-based guidelines for thromboprophylaxis. Anticoagulant therapy plays a critical role in managing patients at risk for VTE. The shortcomings of currently available anticoagulants and potential for patient harm have led to quality improvement initiatives to improve the use of these agents and research to develop agents with improved efficacy and safety profiles. This educational series is designed to educate and inform pharmacists about this "changing face" of anticoagulant therapy.

Educational Activities
Choose from among the following continuing pharmacy education (CPE) opportunities to expand your knowledge of VTE prophylaxis, as well as to learn tips for incorporating that knowledge into practice.

Web-based Activity
Captures the presentations from the live symposium for those unable to attend the ASHP Midyear Clinical Meeting and is approved for 2 hours of CPE (Individuals claiming CPE credit for the live symposium are ineligible to claim credit for this activity)
  »  Go to Web-based Activity

e-Newsletters
Features tips for incorporating information related to improving VTE prophylaxis into practice, as well as updates on emerging information related to anticoagulation and VTE prophylaxis. Sign-up to receive the newsletter.


Informational Interviews with Faculty
Captures content from interviews conducted in December 2009 during which the faculty discussed important concepts related to anticoagulation and VTE prophylaxis
  »  Go to Interviews

Supplement to the American Journal of Health-System Pharmacy
Improving Anticoagulant Use for Prevention of Venous Thromboembolism

Published May 15, 2010, and is approved for 2.5 hours of continuing pharmacy education.
  »  Go to Supplement (PDF)